Evidence map›Paper›PMID 37468968›Full record

ArticleJournal of cheminformatics2023

PINNED: identifying characteristics of druggable human proteins using an interpretable neural network.

Michael Cunningham, Danielle Pins, Zoltán Dezső, Maricel Torrent, Aparna Vasanthakumar, Abhishek Pandey

Abstract readLetter
In one paragraph

Article in Journal of cheminformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael Cunningham *Genomics Research Center, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, 60064, USA. mcunningham@abbvie.com.
Danielle Pins *Information Research, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, 60064, USA.
Zoltán DezsőGenomics Research Center, AbbVie Inc., 1000 Gateway Boulevard, South San Francisco, CA, 94080, USA.
Maricel TorrentSmall Molecule Therapeutics and Platform Technologies, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, 60064, USA.
Aparna VasanthakumarGenomics Research Center, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, 60064, USA.
Abhishek PandeyInformation Research, AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL, 60064, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of human proteins that are amenable to pharmacologic modulation without significant off-target effects remains an important unsolved challenge. Computational methods have been devised to identify features which distinguish between "druggable" and "undruggable" proteins, finding that protein sequence, tissue and cellular localization, biological role, and position in the protein-protein interaction network are all important discriminant factors. However, many prior efforts to automate the assessment of protein druggability suffer from low performance or poor interpretability. We developed a neural network-based machine learning model capable of generating druggability sub-scores based on each of four distinct categories, combining them to form an overall druggability score. The model achieves an excellent performance in separating drugged and undrugged proteins in the human proteome, with an area under the receiver operating characteristic (AUC) of 0.95. Our use of multiple sub-scores allows the assessment of potential protein targets of interest based on distinct contributors to druggability, leading to a more interpretable and holistic model to identify novel targets.

Indexed as

AlphaFoldDark genomeDruggabilityDrug targetInterpretableMachine learningNeural networkProteinProtein pocketProteome

Identifiers

PMID37468968
PMCPMC10354961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.